Cover Image

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

Saved in:

Bibliographic Details
Main Authors:	Yasmin A. Lyons (Author), Michael Frumovitz (Author), Pamela T. Soliman (Author)
Format:	Book
Published:	Elsevier, 2014-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
by: Sushmita Gordhandas, et al.
Published: (2022)

Small Cell Neuroendocrine Carcinoma of the Cervix in Pregnancy: A Case Report and Review
by: Linglan Pan, et al.
Published: (2019)

33 The impact of social media on anxiety and depression among patients with neuroendocrine carcinoma of the cervix: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
by: Reem Saab, et al.
Published: (2023)

Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix
by: Lia Bos, et al.
Published: (2021)

Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
by: Juanjuan Feng, et al.
Published: (2023)

Small cell neuroendocrine carcinoma with adenocarcinoma and high grade squamous intraepithelial neoplasia of the cervix
by: Guralarasan Gurubalan, et al.
Published: (2023)

Malignant Müllerian Mixed Tumor of the Uterine Cervix with a Small Cell Neuroendocrine Carcinoma Component
by: Satoru Munakata, et al.
Published: (2013)

MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
by: Julius Strauss
Published: (2017)

Large Cell Neuroendocrine Carcinoma of the Uterine Cervix Associated with Adenocarcinoma
by: Ma-Lee Ko, et al.
Published: (2007)

Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women
by: Kuang-Leei Chang, et al.
Published: (2024)

Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing
by: Peter G. Rose
Published: (2024)

The first case of recurrent small cell neuroendocrine carcinoma of the uterine cervix successfully treated with robotic-assisted super radical hysterectomy
by: Seiji Mabuchi, et al.
Published: (2021)

Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix
by: Pei-Ying Wu, et al.
Published: (2017)

Neuroendocrine carcinoma of the cervix: A comprehensive clinicopathologic study and literature review
by: Xiaobo Zhang, et al.
Published: (2023)

Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix
by: Hyerim Eum, et al.
Published: (2024)

Chemoradiotherapy in a patient with locally advanced small cell neuroendocrine carcinoma of the cervix complicated by pelvic organ prolapse: A case report
by: Luisa E. Jacomina, et al.
Published: (2021)

KRAS mutations and endometriosis burden of disease
by: Natasha L Orr, et al.
Published: (2023)

Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: A case report and review of literature
by: Yohannis Derbew Molla, et al.
Published: (2024)

Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report
by: Akanksha Suresh, et al.
Published: (2023)

A Rare Presentation of Stage IV Large Cell Neuroendocrine Carcinoma of the Cervix with Metastasis to the Cranium
by: Neema Hooker, et al.
Published: (2018)

How to manage KRAS G12C-mutated advanced non-small-cell lung cancer
by: Biagio Ricciuti, et al.
Published: (2022)

The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients
by: Pi-Chieh Wang, et al.
Published: (2023)

Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum
by: David M. Gershenson, et al.
Published: (2020)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
by: S. Lindsey eDavis, et al.
Published: (2015)

Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix
by: Rongyu Liu, et al.
Published: (2022)

Small Cell Neuroendocrine Cervical Carcinoma: A Case Report
by: Malihe Hasanzadeh, et al.
Published: (2021)

Neuroendocrıne Small Cell Carcinoma of the Endometrium: A Case Presentation
by: Hüseyin Görkemli, et al.
Published: (2011)

Primary Small Cell Undifferentiated (Neuroendocrine) Carcinoma of the Maxillary Sinus
by: Santosh Kumar Yadav, et al.
Published: (2014)

Small-cell neuroendocrine carcinoma of the esophagus: an autopsy case report
by: Mariana Bellaguarda de Castro Sepulvida, et al.
Published: (2014)

Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix
by: Corey M. Gill, et al.
Published: (2020)

Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix: A case report
by: Gizem Teoman, et al.
Published: (2021)

Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024)

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma
by: Tremblay-Gravel Maxime, et al.
Published: (2008)

Retracted: Primary Small Cell Undifferentiated (Neuroendocrine) Carcinoma of the Maxillary Sinus
by: Case Reports in Dentistry
Published: (2014)

Small cell neuroendocrine carcinoma of the nasopharynx: a rare case report
by: Daniela Azevedo, et al.
Published: (2017)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
by: Alice Indini, et al.
Published: (2021)

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
by: Yan Xu, et al.
Published: (2017)

Small cell carcinoma of uterine cervix: A case report
by: Danial Fazilat-panah, et al.
Published: (2024)

MEK inhibitors for the treatment of NRAS mutant melanoma
by: Sarkisian S, et al.
Published: (2018)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020)